Major Release of Certara GlobalSubmit™ Software Enhances the Regulatory Submission Process Announcement Major Release of Certara GlobalSubmit™ Software Enhances the Regulatory Submission Process Radnor, PA – November 25, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…CertaraNovember 25, 2024
Certara Announces New Head of Clinical Pharmacology & Translational Medical Group Announcement Certara Announces New Head of Clinical Pharmacology & Translational Medical Group RADNOR, PA – October 30, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…CertaraOctober 30, 2024
Certara Establishes Certainty Conference in Europe, Creating Space for Drug Development Leaders to Convene Announcement Certara Establishes Certainty Conference in Europe, Creating Space for Drug Development Leaders to Convene Clients are invited to join Certara at this two-day event to further explore and connect…CertaraOctober 24, 2024
Certara Head of AI Recognized in PharmaVoice 100 Announcement Certara Head of AI Recognized in PharmaVoice 100 Certara’s Senior Vice President, Chris Bouton, Head of Artificial Intelligence recognized for his technical innovation,…CertaraOctober 10, 2024
Certara Drug Development & Regulatory Experts Achieve 100th Rare Disease Submission Announcement Certara Drug Development & Regulatory Experts Achieve 100th Rare Disease Submission Dedicated team of global regulatory experts drives the approval of rare disease treatments RADNOR, Pa.…CertaraOctober 1, 2024
Certara Launches Early Development Solution to Reduce Failure Rates in Early-Stage Drug Development Announcement Certara Launches Early Development Solution to Reduce Failure Rates in Early-Stage Drug Development New solution offers early-stage developers a dedicated team of experts with combined experience in end-to-end…CertaraSeptember 19, 2024
CERTARA BRINGS ASIA-PACIFIC DRUG DEVELOPMENT LEADERS TOGETHER AT CERTAINTY Conference. Announcement CERTARA BRINGS ASIA-PACIFIC DRUG DEVELOPMENT LEADERS TOGETHER AT CERTAINTY Conference. Certara client forums in China, Korea, and Japan support collaboration and networking among drug developers…CertaraSeptember 3, 2024
Certara Research Reveals IRA’s Impact on Biosimilar Uptake Announcement Certara Research Reveals IRA’s Impact on Biosimilar Uptake RADNOR, PA - August 15, 2024 -- Certara, Inc., a global leader in model-informed drug…CertaraAugust 15, 2024
University of Florida Wins 2023/24 Certara-Simcyp™ Grant and Partnership Scheme Announcement University of Florida Wins 2023/24 Certara-Simcyp™ Grant and Partnership Scheme RADNOR, PA — July 3, 2024 - Certara, Inc. (Nasdaq: CERT), a global leader in…CertaraJuly 3, 2024
Certara Recognized as a Top Biopharma Workplace for 2024 Announcement Certara Recognized as a Top Biopharma Workplace for 2024 RADNOR, PA – June 12, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…CertaraJune 12, 2024